Abstract
We have evaluated 79 patients affected by bladder cancer T1G3: 31 underwent just endoscopy, 11 radiotherapy, 10 cystectomy and 27 topical chemotherapy. At five years 44 patients were alive and disease free, 7 were alive but recurrent in TA, 3 were alive but in metastatic progression, 17 were died because of the tumor, 3 died because of the therapy, and 5 died disease free. The authors believe that this patients could be treated with BCG as first treatment choice performing cystectomy when relapse or progression occuring.
Publication types
-
Comparative Study
-
English Abstract
MeSH terms
-
Antibiotics, Antineoplastic / therapeutic use
-
Carcinoma, Transitional Cell / mortality
-
Carcinoma, Transitional Cell / pathology
-
Carcinoma, Transitional Cell / therapy*
-
Combined Modality Therapy
-
Cystectomy
-
Disease-Free Survival
-
Endoscopy
-
Epirubicin / therapeutic use
-
Female
-
Follow-Up Studies
-
Humans
-
Male
-
Middle Aged
-
Neoplasm Recurrence, Local
-
Time Factors
-
Urinary Bladder / pathology
-
Urinary Bladder Neoplasms / mortality
-
Urinary Bladder Neoplasms / pathology
-
Urinary Bladder Neoplasms / therapy*
Substances
-
Antibiotics, Antineoplastic
-
Epirubicin